Carson Wealth (CWM LLC)
CRMD icon

Carson Wealth (CWM LLC)’s CorMedix CRMD Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.02K Sell
297
-1,088
-79% -$8.04K ﹤0.01% 5279
2025
Q4 		$16K Sell
1,385
-218
-14% -$2.41K ﹤0.01% 4291
2025
Q3 		$19K Buy
1,603
+11
+0.7% +$133 ﹤0.01% 4146
2025
Q2 		$20K Buy
1,592
+1,321
+487% +$14.6K ﹤0.01% 3900
2025
Q1 		$2K Sell
271
-168
-38% -$1.74K ﹤0.01% 4735
2024
Q4 		$4K Buy
439
+350
+393% +$3.5K ﹤0.01% 4284
2024
Q3 		$1K Buy
89
+67
+305% +$363 ﹤0.01% 4542
2024
Q2 		$0 Buy
22
+17
+340% +$86 ﹤0.01% 4633
2024
Q1 		$0 Buy
+5
New +$17 ﹤0.01% 4372
2021
Q2 		$10K Hold
1,480
– – ﹤0.01% 2094
2021
Q1 		$10K Hold
1,480
– – ﹤0.01% 2094
2020
Q4 		$10K Hold
1,480
– – ﹤0.01% 2094
2020
Q3 		$10K Hold
1,480
– – ﹤0.01% 2094
2020
Q2 		$10K Hold
1,480
– – ﹤0.01% 2094
2020
Q1 		$10K Hold
1,480
– – ﹤0.01% 2094
2019
Q4 		$10K Hold
1,480
– – ﹤0.01% 2094
2019
Q3 		$10K Hold
1,480
– – ﹤0.01% 2094
2019
Q2 		$10K Hold
1,480
– – ﹤0.01% 2094
2019
Q1 		$10K Buy
+1,480
New +$13.3K ﹤0.01% 2094

Other funds holding CRMD

DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Carson Wealth (CWM LLC)'s CRMD Position: Q1 2026 in Review

Carson Wealth (CWM LLC) reduced its CorMedix (CRMD) stake by 79% in Q1 2026, selling an estimated $8.04K and leaving 297 shares worth $2.02K. The position accounts for ﹤0.01% of the portfolio, ranked #5279.

Carson Wealth (CWM LLC) first reported a position in CRMD in Q1 2019 and has held it in 19 quarters since. The position peaked at $20K in Q2 2025. 188 funds tracked by Wall St. Rank hold CRMD as of Q1 2026.

  • Carson Wealth (CWM LLC) held 297 shares of CorMedix worth $2.02K as of Q1 2026.
  • Carson Wealth (CWM LLC) sold 1,088 CorMedix shares in Q1 2026, an estimated $8.04K.
  • CorMedix made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #5279 holding.
  • Carson Wealth (CWM LLC) first reported a position in CorMedix in Q1 2019 and has held it in 19 quarters since.
  • Carson Wealth (CWM LLC)'s CorMedix position peaked at $20K in Q2 2025.
  • 188 funds tracked by Wall St. Rank held CorMedix as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.